Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Chem ; 46(26): 5812-24, 2003 Dec 18.
Article in English | MEDLINE | ID: mdl-14667234

ABSTRACT

In the present study we searched for neutral antagonists for the human histamine H(1)-receptor (H(1)R) by screening newly synthesized ligands that are structurally related to H(1)R agonists for their affinity using radioligand displacement studies and by assessing their functional activity via performing a NF-kappaB driven reporter-gene assay that allows for the detection of both agonistic and inverse agonistic responses. Starting from the endogenous agonist for the H(1)R, histamine, we synthesized and tested various analogues and ultimately identified several compounds with partial inverse agonistic properties and two neutral H(1)-receptor antagonists, namely 2-[2-(4,4-diphenylbutyl)-1H-imidazol-4-yl]ethylamine (histabudifen, 18d) (pK(i) = 5.8, alpha = 0.02) and 2-[2-(5,5-diphenylpentyl)-1H-imidazol-4-yl]ethylamine (histapendifen, 18e) (pK(i) = 5.9, alpha = -0.09).


Subject(s)
Histamine H1 Antagonists/chemical synthesis , Histamine/analogs & derivatives , Histamine/chemical synthesis , Receptors, G-Protein-Coupled , Animals , Binding, Competitive , Cell Line , Chlorocebus aethiops , Genes, Reporter , Histamine/chemistry , Histamine/pharmacology , Histamine Agonists/chemical synthesis , Histamine Agonists/chemistry , Histamine Agonists/pharmacology , Histamine H1 Antagonists/chemistry , Histamine H1 Antagonists/pharmacology , Humans , Inositol Phosphates/biosynthesis , Ligands , NF-kappa B/genetics , Radioligand Assay , Receptors, Histamine/metabolism , Receptors, Histamine H4 , Structure-Activity Relationship
2.
J Mol Graph Model ; 22(1): 55-70, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12798391

ABSTRACT

The homodimeric, pyridoxal 5'-phosphate (PLP)-dependent enzyme glutamine transaminase K/cysteine conjugate beta-lyase (GTK/beta-lyase) has been implicated in the bioactivation of chemopreventive compounds. This paper describes the first homology model of rat renal GTK/beta-lyase and its active site residues, deduced from molecular dynamics (MD) simulations of the binding mode of 13 structurally diverse cysteine S-conjugates and amino acids after Amber-parametrization of PLP. Comparison with Thermus thermophilus aspartate aminotransferase (tAAT) and Trypanosoma cruzi tyrosine aminotransferase (tTAT), used as templates for modeling GTK/beta-lyase, showed that the PLP-binding site of GTK/beta-lyase is highly conserved. Binding of the ligand alpha-carboxylate-group occurred via the conserved residues Arg(432) and Asn(219), and Asn(50) and Gly(70). Two pockets accommodated the various ligand side chains. A small pocket, located directly above PLP, was of a highly hydrophobic and aromatic character. A larger pocket, formed partly by the substrate access channel, was more hydrophilic and notably involved the salt bridge partners Glu(54) and Arg(99*) (* denotes the other subunit). Ligand-binding residues included Leu(51), Phe(71), Tyr(135), Phe(373) and Phe(312*), and pi-stacking interactions were often observed. Tyr(135) and Asn(50) were prominent in hydrogen bonding with the sulfur-atom of cysteine S-conjugates. The observed binding mode of the ligands corresponded well with their experimentally determined inhibitory potency toward GTK/beta-lyase. The current homology model thus provides a starting point for further validation of the role of active site residues in ligand-binding by means of mutagenesis studies. Ultimately, insight in the binding of ligands to GTK/beta-lyase may result in the rational design of new ligands and selective inhibitors.


Subject(s)
Carbon-Sulfur Lyases/chemistry , Lyases/chemistry , Models, Molecular , Transaminases/chemistry , Amino Acid Sequence , Animals , Binding Sites , Carbon-Sulfur Lyases/antagonists & inhibitors , Carbon-Sulfur Lyases/metabolism , Computer Simulation , Enzyme Inhibitors/metabolism , Kidney/enzymology , Ligands , Lyases/antagonists & inhibitors , Lyases/metabolism , Molecular Conformation , Molecular Sequence Data , Protein Conformation , Pyridoxal Phosphate/metabolism , Rats , Sequence Alignment , Signal Transduction , Transaminases/antagonists & inhibitors , Transaminases/metabolism , Tyrosine Transaminase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...